Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 40 for Clostridium difficile infection

Edit search filters
  1. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

    Rochester, MN

  2. Kinetics of Clostridium Difficile Toxin PCR Positivity and Prediction of Recurrent Infection following Metronidazole or Vancomycin Therapy

    Rochester, MN

  3. A Study to Improve Treatment of Clostridium Difficile Infection and using Information Technology to Improve the Care of Patients with Severe Clostridium Difficile Infection

    Rochester, MN

  4. A Study of the Donor Screening Experience and the Outcomes from Fecal Transplant in Patients with C. Difficile Infection

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study to Evaluate the Characteristics and Role of Mucosal Microbiome after Treatment of Clostridium-difficile Infection

    Rochester, MN

  6. A Study of Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection on Vancomycin Resistant Enterococci Status of Patients

    Rochester, MN

  7. A Study to Evaluate the Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridium Difficile Infection

    Rochester, MN

  8. A Study to Evaluate The Role of Mucosal Microbiome in Recurrence of Clostridium Difficile Infection

    Rochester, MN

  9. A Study of the Characteristics and Outcomes of Treatment for C. Diff in Post-Transplant Patients

    Rochester, MN

  10. A Study of Changes in the Fecal Microbiome in Patients with Diarrhea without Clostridium difficile Infection

    Rochester, MN

.

Mayo Clinic Footer